A comprehensive multidisciplinary approach to target the inhibitory kappa B kinase pathway to discover novel therapies in prostate cancer

Project: Research

StatusFinished
Effective start/end date1/04/0830/04/14

Funding

  • Cancer Research UK CRUK: £500,000.00
  • Cancer Research UK CRUK: £601,965.00
  • Cancer Research UK CRUK: £525,000.00
  • Cancer Research UK CRUK: £551,250.00
  • Cancer Research UK CRUK: £578,812.00